RestorLife Med Review
Best for: GLP-1 weight care from a named board-certified physician, with microdosing and strong clinical support
RestorLife Med is a physician-guided GLP-1 telehealth practice (founder Dr. Michael Wasef, MD, licensed in all 50 states) offering compounded semaglutide and tirzepatide for weight loss, including microdose entry options. Plans run $299/month for semaglutide and $399/month for tirzepatide (50% off the first month; multi-month discounts), with B12 protocols and a free quarterly blood test. It carries verifiable LegitScript certification, unlimited care-team messaging, monthly check-ins, and free discreet shipping in all 50 states. Compounded medications are not FDA-approved.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
RestorLife Med stands out for its medical oversight and pharmacy verification.
RestorLife Med at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $299/mo (Compounded semaglutide $299/mo regular (50% off first month = $149; 6-month $199/mo); microdose entry $219/mo. Includes B12 + 1 free blood test/quarter.)
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored RestorLife Med
Each dimension is scored algorithmically from RestorLife Med’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.7/10At $299/mo, RestorLife Med runs about 77% above the $169 median for GLP-1 providers.
Effectiveness25%
9.3/10RestorLife Med offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
8.6/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
9.3/10Key details fully confirmed by our editors; no FDA warning letters on file (last checked 2026-06-28).
Accessibility10%
9.5/10RestorLife Med treats patients in all 50 states.
Support10%
7.1/10RestorLife Med provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this RestorLife Med review
Last checked 2026-06-28- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: high.
GLP-1 medications RestorLife Med offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Compounded semaglutide $299/mo regular (50% off first month = $149; 6-month $199/mo); microdose entry $219/mo. Includes B12 + 1 free blood test/quarter.
Compounded tirzepatide $399/mo regular (50% off first month = $199; 6-month $265/mo); microdose entry $299/mo. Includes B12 + 1 free blood test/quarter.
Ready to get started?
Plans and promotions change often — check RestorLife Med's current pricing and active discounts before you decide.
What we like
- Verifiable LegitScript certification (seal ID 50400451) plus a named board-certified physician (Dr. Michael Wasef, MD) licensed in all 50 states
- Full GLP-1 lineup: compounded semaglutide and tirzepatide, plus gentler microdose entry options
- Generous support — unlimited care-team messaging, monthly check-ins, dosage adjustments, and 1 free blood test per quarter on the GLP-1 protocols
- Available in all 50 states with free priority shipping, discreet packaging, and roughly 48-hour delivery
- Transparent multi-month pricing with 50% off your first month; semaglutide protocols are compounded with B12
Watch-outs
- Compounded medications are not FDA-approved as finished products (the site discloses this) — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- Ongoing pricing is mid-range ($299/mo semaglutide, $399/mo tirzepatide) after the discounted first month
- The specific partner compounding pharmacy is not named
- Also markets hormone therapy and anti-aging peptides, not GLP-1 exclusively
Is RestorLife Med worth it? Our verdict
RestorLife Med positions itself around one thing: GLP-1 weight care from a named board-certified physician, with microdosing and strong clinical support. It runs $299/month — a premium to the category, so the extras need to justify it. It treats patients in all 50 states, so access isn't a barrier.
How much RestorLife Med actually costs
- Compounded semaglutide — $299/month
- Compounded tirzepatide — $399/month
For context, the typical ongoing price across the GLP-1 providers we track is around $169/month, so RestorLife Med's standing rate sits at the premium end.
Medications: what RestorLife Med prescribes
RestorLife Med prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products — the standard trade-off across the compounded-GLP-1 market.
Who RestorLife Med is best for — and who should skip it
A good fit if you…
- live anywhere in the US and want guaranteed access.
Look elsewhere if you…
- want the lowest total cost over 6–12 months — a flat-rate provider will likely beat the ongoing price.
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
RestorLife Med treats patients in all 50 states. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
RestorLife Med costs more than the budget end of the market, so it makes the most sense if its specific extras matter to you. If they don't, you can likely get the same medication for less elsewhere.
Ready to start with RestorLife Med?
Starting at $299/month. See current pricing and start your free consultation.
Alternatives to RestorLife Med
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this RestorLife Med review:
Sources & methodology — as of June 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with RestorLife Med?
Starting at $299/month. See current pricing and start your free consultation.